Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- ChecktodayChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5, indicating a new build/deployment. No visible content or functionality changes were made.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a minor version bump with no visible changes to the study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a minor backend/content-management update.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now displays a new revision tag (v3.6.2) replacing the previous v3.6.0, signaling a more recent deployment of the page.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', signaling enrollment has ended. The treatment section header is reformatted to 'Intervention/Treatment', new help pages are added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), and a new page revision label is introduced ('Revision: v3.6.0').SummaryDifference0.4%

- Check65 days agoChange DetectedThe revision label was updated from v3.5.4 to v3.5.5. This represents a small maintenance release of the page's template or content without altering study details.SummaryDifference0.1%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.